Waselius & Wist represented Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies in its additional equity financing of an aggregate of EUR 13.4 million.
Lawyer involved
Waselius & Wist represented Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies in its additional equity financing of an aggregate of EUR 13.4 million.
Lawyer involved